Literature DB >> 35294606

St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?

Gita Kholghi1, Shirin Arjmandi-Rad2, Mohammad-Reza Zarrindast3, Salar Vaseghi4.   

Abstract

St. John's wort (Hypericum perforatum) is a herbaceous plant containing many bioactive molecules including naphthodianthrones, phloroglucinol derivatives, flavonoids, bioflavonoids, proanthocyanidins, and chlorogenic acid. Evidence has shown the therapeutic effects of St. John's wort and especially its two major active components, hyperforin and hypericin, on different psychiatric and mood disorders such as posttraumatic stress disorder (PTSD), attention-deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), and anxiety disorders. St. John's wort also induces antidepressant effects. In this review study, we aimed to discuss the role of St. John's wort in modulating depression, with respect to the role of different neurotransmitter systems in the brain. We discussed changes in the neurotransmitter levels in depression, and following use of St. John's wort. It was concluded that changes in the function and level of neurotransmitters in depression are complex. Also, St. John's wort can induce inconsistent effects on neurotransmitter levels. We also found that glutamate and acetylcholine may be the most important neurotransmitters to study in future works, because the function of both neurotransmitters in depression is unclear. In addition, St. John's wort induces a dualistic modulation on the activity of cholinergic signaling, which can be an interesting topic for future studies.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Depression; Hypericum perforatum; Neurotransmitters; St. Johnʼs wort

Mesh:

Substances:

Year:  2022        PMID: 35294606     DOI: 10.1007/s00210-022-02229-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  127 in total

1.  SOME BEHAVIORAL CHANGES IN MAN FOLLOWING ANTICHOLINESTERASE ADMINISTRATION.

Authors:  M B BOWERS; E GOODMAN; V M SIM
Journal:  J Nerv Ment Dis       Date:  1964-04       Impact factor: 2.254

2.  Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression.

Authors:  Kirsten Behnke; Gert Saaby Jensen; Hans-Joachim Graubaum; Joerg Gruenwald
Journal:  Adv Ther       Date:  2002 Jan-Feb       Impact factor: 3.845

Review 3.  The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?

Authors:  Chadi G Abdallah; Gerard Sanacora; Ronald S Duman; John H Krystal
Journal:  Pharmacol Ther       Date:  2018-05-25       Impact factor: 12.310

Review 4.  Adult hippocampal neurogenesis and cognitive flexibility - linking memory and mood.

Authors:  Christoph Anacker; René Hen
Journal:  Nat Rev Neurosci       Date:  2017-05-04       Impact factor: 34.870

5.  Therapeutic Potential of Curcumin in Reversing the Depression and Associated Pseudodementia via Modulating Stress Hormone, Hippocampal Neurotransmitters, and BDNF Levels in Rats.

Authors:  Asia Afzal; Zehra Batool; Sadia Sadir; Laraib Liaquat; Sidrah Shahzad; Saiqa Tabassum; Saara Ahmad; Noor Kamil; Tahira Perveen; Saida Haider
Journal:  Neurochem Res       Date:  2021-08-18       Impact factor: 3.996

Review 6.  Serotonin and beyond: therapeutics for major depression.

Authors:  Pierre Blier; Mostafa El Mansari
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

7.  Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia.

Authors:  L Andrén; A Andreasson; R Eggertsen
Journal:  Eur J Clin Pharmacol       Date:  2007-08-15       Impact factor: 2.953

8.  NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.

Authors:  Anita E Autry; Megumi Adachi; Elena Nosyreva; Elisa S Na; Maarten F Los; Peng-fei Cheng; Ege T Kavalali; Lisa M Monteggia
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

9.  (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism.

Authors:  Yukio Ago; Wataru Tanabe; Momoko Higuchi; Shinji Tsukada; Tatsunori Tanaka; Takumi Yamaguchi; Hisato Igarashi; Rei Yokoyama; Kaoru Seiriki; Atsushi Kasai; Takanobu Nakazawa; Shinsaku Nakagawa; Kenji Hashimoto; Hitoshi Hashimoto
Journal:  Int J Neuropsychopharmacol       Date:  2019-10-01       Impact factor: 5.176

Review 10.  Dopamine System Dysregulation in Major Depressive Disorders.

Authors:  Pauline Belujon; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2017-12-01       Impact factor: 5.176

View more
  1 in total

Review 1.  Biological Role of Nutrients, Food and Dietary Patterns in the Prevention and Clinical Management of Major Depressive Disorder.

Authors:  Miguel A Ortega; Óscar Fraile-Martínez; Cielo García-Montero; Miguel Angel Alvarez-Mon; Guillermo Lahera; Jorge Monserrat; Maria Llavero-Valero; Luis Gutiérrez-Rojas; Rosa Molina; Roberto Rodríguez-Jimenez; Javier Quintero; Melchor Alvarez De Mon
Journal:  Nutrients       Date:  2022-07-28       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.